CONTACT US
FOR ADDITIONAL INFORMATION ABOUT MYOBLOC:
Circle of Care Provider Portal
Phone:
(888) 461-2255 Phone:
(888) 461-2255 Hours: M-F, 8 AM- 8 PM ET
Ordering Fax:
(614) 553-5485
Ordering Fax:
(614) 553-5485
Circle of Care Provider Portal
Phone:
(888) 461-2255 Phone:
(888) 461-2255 Hours: M-F, 8 AM- 8 PM ET
Ordering Fax:
(614) 553-5485
Ordering Fax:
(614) 553-5485
MYOBLOC® injection is indicated for:
IMPORTANT SAFETY INFORMATION
WARNING: DISTANT SPREAD OF TOXIN EFFECT
See full prescribing information for complete boxed WARNING.
The effects of MYOBLOC® and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults, particularly in those patients who have an underlying condition that would predispose them to these symptoms.
CONTRAINDICATIONS
MYOBLOC is contraindicated in patients with:
WARNING AND PRECAUTIONS
MOST COMMON ADVERSE REACTIONS (>5% of patients and >5% more than placebo)
Cervical Dystonia: dry mouth, dysphagia, injection site pain, headache
Chronic Sialorrhea: dry mouth, dysphagia
DRUG INTERACTIONS
Aminoglycosides and Other Agents Interfering with Neuromuscular Transmission: Co-administration of MYOBLOC and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Anticholinergic Drugs: Use of anticholinergic drugs after administration of MYOBLOC may potentiate systemic anticholinergic effects. Other Botulinum Neurotoxin Products: The effect of administering different botulinum toxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin. Muscle Relaxants: Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of MYOBLOC.
Please see the full Prescribing Information, including Boxed WARNING and Medication Guide.
MYOBLOC® injection is indicated for:
IMPORTANT SAFETY INFORMATION
WARNING: DISTANT SPREAD OF TOXIN EFFECT
See full prescribing information for complete boxed WARNING.
The effects of MYOBLOC® and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults, particularly in those patients who have an underlying condition that would predispose them to these symptoms.
CONTRAINDICATIONS
MYOBLOC is contraindicated in patients with:
WARNING AND PRECAUTIONS
MOST COMMON ADVERSE REACTIONS (>5% of patients and >5% more than placebo)
Cervical Dystonia: dry mouth, dysphagia, injection site pain, headache
Chronic Sialorrhea: dry mouth, dysphagia
DRUG INTERACTIONS
Aminoglycosides and Other Agents Interfering with Neuromuscular Transmission: Co-administration of MYOBLOC and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Anticholinergic Drugs: Use of anticholinergic drugs after administration of MYOBLOC may potentiate systemic anticholinergic effects. Other Botulinum Neurotoxin Products: The effect of administering different botulinum toxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin. Muscle Relaxants: Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of MYOBLOC.
Please see the full Prescribing Information, including Boxed WARNING and Medication Guide.